Blue Shield Biotech Faces Bankruptcy Proceedings After Missing Debt Payments
The Nanjing Qixia District People’s Court has accepted a bankruptcy liquidation case for Blue Shield...
Blue Shield Biotech
Blue Shield Pharma’s LD013 CAR-T Therapy Approved for Clinical Trials
China-based Blue Shield Biotech’s in-house developed LD013, an autologous chimeric antigen receptor (CAR)-T cell therapy,...